Given the role of chronic liver diseases such as HBV and HCV in the development of portal hypertension, these findings suggest that genetic variations in IL-10 and its receptor may play a role in modulating the progression of liver fibrosis, and by extension, portal hypertension. The gene discussed is IL10; the disease is portal hypertension.